Transfusion-transmissible infections monitoring system laboratory & risk factor database coordinating center

Ended Awarded Last action

Contract number
HHSF22301001T
Awardee
Awarding agency
Obligated
$5,823,074

Award facts

Opportunity
Contract value 100% obligated
$5,823,074.23 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Scottsdale, AZ 85257, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Close Out P00012 -$2,654,645
Other Administrative Action P00011 $90,760
Other Administrative Action P00010 $0
Other Administrative Action P00009 $0
Exercise an Option P00008 $1,728,316
Exercise an Option P00007 $1,682,862
Other Administrative Action P00006 $0
Funding Only Action 5 $1,651,939
Other Administrative Action 4 $0
Supplemental Agreement for work within scope 3 $43,966
Exercise an Option 2 $1,621,924
Other Administrative Action 1 $0
Original award $1,657,952
Show all 13

About this award

Written by GovTribe AI ·

This is a $5,823,074.23 firm fixed price delivery order contract awarded by the Food and Drug Administration to the non-profit organization Vitalant Research Institute (VRI) for the Transfusion-Transmissible Infections Monitoring System (TTIMS) Laboratory & Risk Factor Database Coordinating Center. The contract has no set-aside designation and was awarded on September 23, 2016, with a completion date of September 24, 2021.

VRI, the prime contractor, has subcontracted with several other non-profit organizations including Creative Testing Solutions, New York Blood Center, American Red Cross, and OneBlood to provide various support functions for the TTIMS program. These include recruiting and enrolling participants, providing data and coded biospecimens, and collaborating on analysis and reporting. The TTIMS program aims to monitor and evaluate HIV, hepatitis C, and hepatitis B infections among blood donors in the United States. This contract supports the FDA's efforts to ensure the safety and quality of the nation's blood supply.

Quick answers

Who was awarded contract HHSF22301001T?

HHSF22301001T was awarded to Vitalant by Food and Drug Administration (Department of Health and Human Services) on September 23, 2016.

How much is contract HHSF22301001T worth?

The government has obligated $5,823,074 on HHSF22301001T.

Is contract HHSF22301001T an order under another contract?

Yes. HHSF22301001T is a delivery order under HHSF223201610043I, an indefinite delivery contract.

Was contract HHSF22301001T competed?

The extent of competition for HHSF22301001T was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login